Laurent POIROT

Person

Paris, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Method for generating t-cells compatible for allogenic transplantation
- Patent number 12,252,699
- Issue date Mar 18, 2025
- Cellectis
- Laurent Poirot
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted gene integration of CRS inhibitor genes for improved immun...
- Patent number 12,221,478
- Issue date Feb 11, 2025
- Cellectis
- Brian Busser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted gene integration of NK inhibitors genes for improved immun...
- Patent number 12,209,125
- Issue date Jan 28, 2025
- Cellectis
- Brian Busser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cellular immunotherapy for repetitive administration
- Patent number 12,144,825
- Issue date Nov 19, 2024
- Cellectis
- David Sourdive
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering T cells for immunotherapy by using RNA-guid...
- Patent number 11,959,091
- Issue date Apr 16, 2024
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Engineered immune cells resistant to tumor microenvironment
- Patent number 11,903,968
- Issue date Feb 20, 2024
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering allogeneic and immunosuppressive resistant...
- Patent number 11,891,614
- Issue date Feb 6, 2024
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeted gene insertion for improved immune cells therapy
- Patent number 11,873,511
- Issue date Jan 16, 2024
- Cellectis
- Brian Busser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for generating T-cells compatible for allogenic transplantation
- Patent number 11,820,996
- Issue date Nov 21, 2023
- Cellectis
- Laurent Poirot
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cells for immunotherapy engineered for targeting antigen present bo...
- Patent number 11,692,169
- Issue date Jul 4, 2023
- Cellectis
- Philippe Duchateau
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Methods for engineering allogeneic and immunosuppressive resistant...
- Patent number 11,603,539
- Issue date Mar 14, 2023
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of pre T alpha or functional variant thereof for expanding TCR...
- Patent number 11,414,674
- Issue date Aug 16, 2022
- Cellectis
- Roman Galetto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for engineering T cells for immunotherapy by using RNA-guid...
- Patent number 11,365,430
- Issue date Jun 21, 2022
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering highly active T cell for immunotherapy
- Patent number 11,311,575
- Issue date Apr 26, 2022
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering allogeneic and highly active t cell for imm...
- Patent number 11,304,975
- Issue date Apr 19, 2022
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of pre T alpha or functional variant thereof for expanding TCR...
- Patent number 11,274,316
- Issue date Mar 15, 2022
- Cellectis
- Roman Galetto
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for engineering allogeneic T cell to increase their persist...
- Patent number 11,186,824
- Issue date Nov 30, 2021
- Cellectis
- Philippe Duchateau
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Inhibitory chimeric antigen receptors
- Patent number 11,072,644
- Issue date Jul 27, 2021
- Allogene Therapeutics, Inc.
- Arvind Rajpal
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors with integrated controllable functions
- Patent number 10,988,542
- Issue date Apr 27, 2021
- Cellectis
- Alexandre Juillerat
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of engineering drug-specific hypersensitive t-cells for immu...
- Patent number 10,894,093
- Issue date Jan 19, 2021
- Cellectis
- Julien Valton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering T cells for immunotherapy by using RNA-guid...
- Patent number 10,870,864
- Issue date Dec 22, 2020
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cells for immunotherapy engineered for targeting antigen present bo...
- Patent number 10,836,998
- Issue date Nov 17, 2020
- Cellectis
- Philippe Duchateau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for generating immune cells resistant to arginine and/or try...
- Patent number 10,765,728
- Issue date Sep 8, 2020
- Cellectis
- Laurent Poirot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for engineering T cells for immunotherapy by using RNA-guid...
- Patent number 10,584,352
- Issue date Mar 10, 2020
- Cellectis
- Philippe Duchateau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of pre T alpha or functional variant thereof for expanding TCR...
- Patent number 10,517,896
- Issue date Dec 31, 2019
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for modulating car-induced immune cells activity
- Patent number 10,472,613
- Issue date Nov 12, 2019
- Cellectis
- Philippe Duchateau
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of preTalpha or functional variant thereof for expanding TCRalp...
- Patent number 10,426,795
- Issue date Oct 1, 2019
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering allogeneic and immunosuppressive resistant...
- Patent number 10,363,270
- Issue date Jul 30, 2019
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of pre T alpha or functional variant thereof for expanding TCR...
- Patent number 10,286,007
- Issue date May 14, 2019
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of engineering multi-input signal sensitive T cell for immun...
- Patent number 10,239,948
- Issue date Mar 26, 2019
- Cellectis
- Alexandre Juillerat
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ENHANCING EFFICACY OF T-CELL-MEDIATED IMMUNOTHERAPY BY MODULATING C...
- Publication number 20250057952
- Publication date Feb 20, 2025
- CELLECTIS S.A.
- Shipra DAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLULAR IMMUNOTHERAPY FOR REPETITIVE ADMINISTRATION
- Publication number 20250034641
- Publication date Jan 30, 2025
- CELLECTIS
- David SOURDIVE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITORY CHIMERIC ANTIGEN RECEPTORS
- Publication number 20240360196
- Publication date Oct 31, 2024
- Allogene Therapeutics, Inc.
- ARVIND RAJPAL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT...
- Publication number 20240309397
- Publication date Sep 19, 2024
- CELLECTIS
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NEW ANTI-MUC1 CARS AND GENE EDITED IMMUNE CELLS FOR SOLID TUMORS CA...
- Publication number 20240197880
- Publication date Jun 20, 2024
- CELLECTIS S.A.
- Beatriz ARANDA-ORGILLES
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED GENE INSERTION FOR IMPROVED IMMUNE CELLS THERAPY
- Publication number 20240141293
- Publication date May 2, 2024
- CELLECTIS
- Brian BUSSER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR GENERATING T-CELLS COMPATIBLE FOR ALLOGENIC TRANSPLANTATION
- Publication number 20240026376
- Publication date Jan 25, 2024
- CELLECTIS
- Laurent POIROT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BO...
- Publication number 20230357719
- Publication date Nov 9, 2023
- CELLECTIS
- Philippe DUCHATEAU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS TO GENETICALLY MODIFY CELLS FOR DELIVERY OF THERAPEUTIC PRO...
- Publication number 20230279440
- Publication date Sep 7, 2023
- CELLECTIS S.A.
- Alexandre JUILLERAT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DUAL CAR-T CELLS
- Publication number 20230279350
- Publication date Sep 7, 2023
- CELLECTIS S.A.
- André CHOULIKA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
T-CELLS EXPRESSING IMMUNE CELL ENGAGERS IN ALLOGENIC SETTINGS
- Publication number 20230248825
- Publication date Aug 10, 2023
- CELLECTIS S.A.
- Shipra DAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...
- Publication number 20230201260
- Publication date Jun 29, 2023
- CELLECTIS
- Roman GALETTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TAL- effector nuclease (TALEN) -MODIFIED ALLOGENIC CELLS SUITABLE F...
- Publication number 20230138915
- Publication date May 4, 2023
- CELLECTIS
- Philippe DUCHATEAU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR ENGINEERING HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY
- Publication number 20230056268
- Publication date Feb 23, 2023
- CELLECTIS
- Roman GALETTO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...
- Publication number 20230050345
- Publication date Feb 16, 2023
- CELLECTIS
- Roman GALETTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR...
- Publication number 20220348955
- Publication date Nov 3, 2022
- CELLECTIS
- Roman Galetto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELLULAR IMMUNOTHERAPY FOR REPETITIVE ADMINISTRATION
- Publication number 20220233588
- Publication date Jul 28, 2022
- CELLECTIS
- David SOURDIVE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR...
- Publication number 20220177914
- Publication date Jun 9, 2022
- CELLECTIS
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITORY CHIMERIC ANTIGEN RECEPTORS
- Publication number 20220033462
- Publication date Feb 3, 2022
- Allogene Therapeutics, Inc.
- ARVIND RAJPAL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR...
- Publication number 20210220405
- Publication date Jul 22, 2021
- CELLECTIS
- Roman Galetto
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUID...
- Publication number 20210147868
- Publication date May 20, 2021
- CELLECTIS
- Philippe DUCHATEAU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED IMMUNE CELLS RESISTANT TO TUMOR MICROENVIRONMENT
- Publication number 20210128613
- Publication date May 6, 2021
- CELLECTIS
- Philippe DUCHATEAU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BO...
- Publication number 20200407682
- Publication date Dec 31, 2020
- CELLECTIS
- Philippe DUCHATEAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED GENE INTEGRATION OF CRS INHIBITOR GENES FOR IMPROVED IMMUN...
- Publication number 20200407694
- Publication date Dec 31, 2020
- CELLECTIS
- Brian BUSSER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR IMPROVING PRODUCTION OF CAR T CELLS
- Publication number 20200332004
- Publication date Oct 22, 2020
- CELLECTIS
- Alex BOYNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT...
- Publication number 20200281979
- Publication date Sep 10, 2020
- CELLECTIS
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUID...
- Publication number 20200277625
- Publication date Sep 3, 2020
- CELLECTIS
- Philippe DUCHATEAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED GENE INTEGRATION OF NK INHIBITORS GENES FOR IMPROVED IMMUN...
- Publication number 20200237823
- Publication date Jul 30, 2020
- CELLECTIS
- Brian BUSSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED GENE INSERTION FOR IMPROVED IMMUNE CELLS THERAPY
- Publication number 20200224163
- Publication date Jul 16, 2020
- CELLECTIS
- Brian BUSSER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF ANTIGEN-DEPENDENT CHIMERIC ANTIGEN RECEPTOR (CAR) IMMUNE...
- Publication number 20200216515
- Publication date Jul 9, 2020
- CELLECTIS
- Philippe DUCHATEAU
- C07 - ORGANIC CHEMISTRY

Laurent POIROT

Person

Patents Grantslast 30 patents

Method for generating t-cells compatible for allogenic transplantation

Targeted gene integration of CRS inhibitor genes for improved immun...

Targeted gene integration of NK inhibitors genes for improved immun...

Cellular immunotherapy for repetitive administration

Methods for engineering T cells for immunotherapy by using RNA-guid...

Engineered immune cells resistant to tumor microenvironment

Methods for engineering allogeneic and immunosuppressive resistant...

Targeted gene insertion for improved immune cells therapy

Method for generating T-cells compatible for allogenic transplantation

Cells for immunotherapy engineered for targeting antigen present bo...

Methods for engineering allogeneic and immunosuppressive resistant...

Use of pre T alpha or functional variant thereof for expanding TCR...

Methods for engineering T cells for immunotherapy by using RNA-guid...

Methods for engineering highly active T cell for immunotherapy

Methods for engineering allogeneic and highly active t cell for imm...

Use of pre T alpha or functional variant thereof for expanding TCR...

Methods for engineering allogeneic T cell to increase their persist...

Inhibitory chimeric antigen receptors

Chimeric antigen receptors with integrated controllable functions

Method of engineering drug-specific hypersensitive t-cells for immu...

Methods for engineering T cells for immunotherapy by using RNA-guid...

Cells for immunotherapy engineered for targeting antigen present bo...

Method for generating immune cells resistant to arginine and/or try...

Methods for engineering T cells for immunotherapy by using RNA-guid...

Use of pre T alpha or functional variant thereof for expanding TCR...

Method for modulating car-induced immune cells activity

Use of preTalpha or functional variant thereof for expanding TCRalp...

Methods for engineering allogeneic and immunosuppressive resistant...

Use of pre T alpha or functional variant thereof for expanding TCR...

Method of engineering multi-input signal sensitive T cell for immun...

Patents Applicationslast 30 patents

ENHANCING EFFICACY OF T-CELL-MEDIATED IMMUNOTHERAPY BY MODULATING C...

CELLULAR IMMUNOTHERAPY FOR REPETITIVE ADMINISTRATION

INHIBITORY CHIMERIC ANTIGEN RECEPTORS

METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT...

NEW ANTI-MUC1 CARS AND GENE EDITED IMMUNE CELLS FOR SOLID TUMORS CA...

TARGETED GENE INSERTION FOR IMPROVED IMMUNE CELLS THERAPY

METHOD FOR GENERATING T-CELLS COMPATIBLE FOR ALLOGENIC TRANSPLANTATION

CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BO...

METHODS TO GENETICALLY MODIFY CELLS FOR DELIVERY OF THERAPEUTIC PRO...

DUAL CAR-T CELLS

T-CELLS EXPRESSING IMMUNE CELL ENGAGERS IN ALLOGENIC SETTINGS

METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...

TAL- effector nuclease (TALEN) -MODIFIED ALLOGENIC CELLS SUITABLE F...

METHODS FOR ENGINEERING HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY

METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...

USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR...

CELLULAR IMMUNOTHERAPY FOR REPETITIVE ADMINISTRATION

USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR...

INHIBITORY CHIMERIC ANTIGEN RECEPTORS

USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR...

METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUID...

ENGINEERED IMMUNE CELLS RESISTANT TO TUMOR MICROENVIRONMENT

CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BO...

TARGETED GENE INTEGRATION OF CRS INHIBITOR GENES FOR IMPROVED IMMUN...

METHOD FOR IMPROVING PRODUCTION OF CAR T CELLS

METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT...

METHODS FOR ENGINEERING T CELLS FOR IMMUNOTHERAPY BY USING RNA-GUID...

TARGETED GENE INTEGRATION OF NK INHIBITORS GENES FOR IMPROVED IMMUN...

TARGETED GENE INSERTION FOR IMPROVED IMMUNE CELLS THERAPY

METHODS OF ANTIGEN-DEPENDENT CHIMERIC ANTIGEN RECEPTOR (CAR) IMMUNE...